Vincerx Historical Balance Sheet

VINC Stock  USD 0.28  0.02  7.69%   
Trend analysis of Vincerx Pharma balance sheet accounts such as Total Assets of 17.3 M, Other Current Liab of 744.8 K, Total Current Liabilities of 7.5 M or Total Stockholder Equity of 10.7 M provides information on Vincerx Pharma's total assets, liabilities, and equity, which is the actual value of Vincerx Pharma to its prevalent stockholders. By breaking down trends over time using Vincerx Pharma balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Vincerx Pharma latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Vincerx Pharma is a good buy for the upcoming year.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vincerx Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Vincerx Stock refer to our How to Trade Vincerx Stock guide.

About Vincerx Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Vincerx Pharma at a specified time, usually calculated after every quarter, six months, or one year. Vincerx Pharma Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Vincerx Pharma and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Vincerx currently owns. An asset can also be divided into two categories, current and non-current.

Vincerx Pharma Balance Sheet Chart

At present, Vincerx Pharma's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Liabilities Total is expected to grow to about 2.3 M, whereas Total Assets are forecasted to decline to about 17.3 M.

Net Tangible Assets

The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.

Net Invested Capital

The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.

Total Current Assets

The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.
Most accounts from Vincerx Pharma's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Vincerx Pharma current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vincerx Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Vincerx Stock refer to our How to Trade Vincerx Stock guide.At present, Vincerx Pharma's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Liabilities Total is expected to grow to about 2.3 M, whereas Total Assets are forecasted to decline to about 17.3 M.
 2021 2022 2023 2024 (projected)
Other Current Liabilities10.4M3.0M784K744.8K
Total Assets117.7M59.3M18.2M17.3M

Vincerx Pharma balance sheet Correlations

0.60.921.00.9-0.370.620.790.010.70.90.710.91.00.61.00.6-0.190.630.760.42-0.010.01-0.33-0.1-0.2
0.60.40.630.520.020.090.10.110.330.680.170.340.630.010.640.01-0.180.020.20.2-0.110.11-0.180.120.1
0.920.40.890.97-0.70.820.94-0.350.880.930.91.00.890.830.880.830.140.880.640.090.3-0.35-0.09-0.46-0.54
1.00.630.890.88-0.320.570.750.050.660.890.660.881.00.551.00.55-0.240.570.770.46-0.050.05-0.36-0.05-0.14
0.90.520.970.88-0.680.740.89-0.40.880.950.880.960.880.80.870.80.110.830.610.030.4-0.4-0.12-0.49-0.5
-0.370.02-0.7-0.32-0.68-0.88-0.760.77-0.91-0.6-0.9-0.71-0.32-0.92-0.3-0.92-0.75-0.93-0.020.62-0.80.77-0.520.950.96
0.620.090.820.570.74-0.880.84-0.420.930.710.950.840.570.920.560.920.590.930.2-0.290.48-0.420.44-0.71-0.86
0.790.10.940.750.89-0.760.84-0.410.850.760.940.950.750.930.730.930.180.940.650.020.46-0.41-0.06-0.56-0.6
0.010.11-0.350.05-0.40.77-0.42-0.41-0.53-0.33-0.5-0.350.05-0.540.08-0.54-0.65-0.610.160.77-0.81.0-0.350.860.73
0.70.330.880.660.88-0.910.930.85-0.530.850.970.880.660.930.640.930.540.920.25-0.330.61-0.530.34-0.76-0.82
0.90.680.930.890.95-0.60.710.76-0.330.850.790.910.890.670.890.670.140.720.490.040.25-0.33-0.06-0.4-0.46
0.710.170.90.660.88-0.90.950.94-0.50.970.790.910.660.980.650.980.470.970.37-0.250.6-0.50.26-0.74-0.8
0.90.341.00.880.96-0.710.840.95-0.350.880.910.910.880.850.860.850.140.890.650.090.31-0.35-0.09-0.47-0.55
1.00.630.891.00.88-0.320.570.750.050.660.890.660.880.551.00.55-0.240.570.770.46-0.050.05-0.36-0.05-0.14
0.60.010.830.550.8-0.920.920.93-0.540.930.670.980.850.550.531.00.490.980.35-0.30.68-0.540.28-0.79-0.82
1.00.640.881.00.87-0.30.560.730.080.640.890.650.861.00.530.53-0.250.550.760.47-0.080.08-0.37-0.02-0.12
0.60.010.830.550.8-0.920.920.93-0.540.930.670.980.850.551.00.530.490.980.35-0.30.68-0.540.28-0.79-0.82
-0.19-0.180.14-0.240.11-0.750.590.18-0.650.540.140.470.14-0.240.49-0.250.490.48-0.63-0.90.66-0.650.93-0.84-0.89
0.630.020.880.570.83-0.930.930.94-0.610.920.720.970.890.570.980.550.980.480.37-0.290.62-0.610.23-0.78-0.83
0.760.20.640.770.61-0.020.20.650.160.250.490.370.650.770.350.760.35-0.630.370.7-0.160.16-0.780.20.21
0.420.20.090.460.030.62-0.290.020.77-0.330.04-0.250.090.46-0.30.47-0.3-0.9-0.290.7-0.780.77-0.80.820.73
-0.01-0.110.3-0.050.4-0.80.480.46-0.80.610.250.60.31-0.050.68-0.080.680.660.62-0.16-0.78-0.80.47-0.92-0.74
0.010.11-0.350.05-0.40.77-0.42-0.411.0-0.53-0.33-0.5-0.350.05-0.540.08-0.54-0.65-0.610.160.77-0.8-0.350.860.73
-0.33-0.18-0.09-0.36-0.12-0.520.44-0.06-0.350.34-0.060.26-0.09-0.360.28-0.370.280.930.23-0.78-0.80.47-0.35-0.62-0.72
-0.10.12-0.46-0.05-0.490.95-0.71-0.560.86-0.76-0.4-0.74-0.47-0.05-0.79-0.02-0.79-0.84-0.780.20.82-0.920.86-0.620.94
-0.20.1-0.54-0.14-0.50.96-0.86-0.60.73-0.82-0.46-0.8-0.55-0.14-0.82-0.12-0.82-0.89-0.830.210.73-0.740.73-0.720.94
Click cells to compare fundamentals

Vincerx Pharma Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Vincerx Pharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vincerx Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vincerx Pharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vincerx Pharma Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vincerx Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Vincerx Stock refer to our How to Trade Vincerx Stock guide.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vincerx Pharma. If investors know Vincerx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vincerx Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.14)
Return On Assets
(0.66)
Return On Equity
(1.42)
The market value of Vincerx Pharma is measured differently than its book value, which is the value of Vincerx that is recorded on the company's balance sheet. Investors also form their own opinion of Vincerx Pharma's value that differs from its market value or its book value, called intrinsic value, which is Vincerx Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vincerx Pharma's market value can be influenced by many factors that don't directly affect Vincerx Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vincerx Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vincerx Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vincerx Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.